Transforming Clinical Trials with Blockchain Technology: Innovations and Challenges in 2024

Rymedi is a blockchain-enabled patient and population healthcare data management company that empowers life science organizations to improve human health. We provide a secure, transparent, and efficient platform for engaging…

Continue ReadingTransforming Clinical Trials with Blockchain Technology: Innovations and Challenges in 2024

Rymedi Announces Strategic Partnership to Improve Patient Experience and Advance Patient Registry Supported by Web3 and DeSci

May 2, 2024 / Rymedi and Precision Genetics, two leading pioneers in healthcare technology solutions, proudly announce their strategic partnership aimed at transforming health outcomes and efficiencies through precision medicine.…

Continue ReadingRymedi Announces Strategic Partnership to Improve Patient Experience and Advance Patient Registry Supported by Web3 and DeSci

BioSpy’s Prostate Cancer Screening Breakthrough Runs on Rymedi’s Blockchain-Enabled Clinical Diagnostics Platform

Rymedi is proud to announce its newest collaboration with BioSpy, the creators of Prostate IQ®, a next generation prostate cancer screening test. This new partnership will ensure the highest efficiency and security of…

Continue ReadingBioSpy’s Prostate Cancer Screening Breakthrough Runs on Rymedi’s Blockchain-Enabled Clinical Diagnostics Platform

Rymedi Raises $9M to Expand Impact on Global Healthcare Infrastructure with Advanced Blockchain-Secured Data Platform

Rymedi has completed a Series A totaling $9 million with plans to expand the reach of our platform. The round was co-led by RW3 Ventures and White Star Capital with participation from Blockchange Ventures, Avalanche’s…

Continue ReadingRymedi Raises $9M to Expand Impact on Global Healthcare Infrastructure with Advanced Blockchain-Secured Data Platform